Paper39385196
US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.
Ren L and 13 others. J Nanobiotechnology, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy. Papers, record 39385196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39385196
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Multimodal Imaging | Major topic |
| Polylactic Acid-Polyglycolic Acid Copolymer | Major topic |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| Magnetic Resonance Imaging | |
| Neoplasms | |
| Fluorocarbons | |
| Polyethyleneimine | |
| Humans | |
| Genetic Engineering | |
| Mice, Inbred BALB C | |
| Photoacoustic Techniques | |
| Female | |
| Nanoparticles | |
| Epirubicin | |
| Polyglycolic Acid | |
| Lactic Acid | |
| High-Intensity Focused Ultrasound Ablation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| I01 HX000132 | HSRD VA | United States | I01HX000132 | PubMed and NIH | NIH RePORTER |
| CSTB2023NSCQ-BHX0132 | Chongqing Natural Science Foundation Post doctoral Fund | PubMed | PubMed |
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33010331 | Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation. | J Control Release | 2021 | https://conductscience.org/library/papers/33010331 | PubMed |
| 2 | 30659129 | Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer. | J Natl Compr Canc Netw | 2019 | https://conductscience.org/library/papers/30659129 | PubMed |
| 3 | 37362333 | Tumor-homing bacterium-adsorbed liposomes encapsulating perfluorohexane/doxorubicin enhance pulsed-focused ultrasound for tumor therapy. | RSC Adv | 2023 | https://conductscience.org/library/papers/37362333 | PubMed |
| 4 | 37926100 | Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial. | Lancet Oncol | 2023 | https://conductscience.org/library/papers/37926100 | PubMed |
| 5 | 34818953 | Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. | Crit Rev Anal Chem | 2023 | https://conductscience.org/library/papers/34818953 | PubMed |
| 6 | 38159557 | Factors associated with thermal injury of abdominal skin in focused ultrasound ablation of uterine fibroids. | Int J Hyperthermia | 2024 | https://conductscience.org/library/papers/38159557 | PubMed |
| 7 | 35931281 | Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy. | Acta Biomater | 2022 | https://conductscience.org/library/papers/35931281 | PubMed |
| 8 | 35814614 | US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/35814614 | PubMed |
| 9 | 29507623 | Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound. | Theranostics | 2018 | https://conductscience.org/library/papers/29507623 | PubMed |
| 10 | 36937280 | Synergistic antibacterial effects of ultrasound combined nanoparticles encapsulated with cellulase and levofloxacin on Bacillus Calmette-Guérin biofilms. | Front Microbiol | 2023 | https://conductscience.org/library/papers/36937280 | PubMed |
| 11 | 34374945 | High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications. | Ann Biomed Eng | 2021 | https://conductscience.org/library/papers/34374945 | PubMed |
| 12 | 38442747 | Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38442747 | PubMed |
| 13 | 33898560 | A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. | Hepatobiliary Surg Nutr | 2021 | https://conductscience.org/library/papers/33898560 | PubMed |
| 14 | 38598407 | Dynamic Mode Decomposition for Transient Cavitation Bubbles Imaging in Pulsed High-Intensity Focused Ultrasound Therapy. | IEEE Trans Ultrason Ferroelectr Freq Control | 2024 | https://conductscience.org/library/papers/38598407 | PubMed |
| 15 | 31339599 | Comparative Study of Pulsed Versus Continuous High-Intensity Focused Ultrasound Ablation Using In Vitro and In Vivo Models. | J Ultrasound Med | 2020 | https://conductscience.org/library/papers/31339599 | PubMed |
| 16 | 38409678 | Truly Tiny Acoustic Biomolecules for Ultrasound Imaging and Therapy. | Adv Mater | 2024 | https://conductscience.org/library/papers/38409678 | PubMed |
| 17 | 35300712 | Ultrasound and nanomaterial: an efficient pair to fight cancer. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/35300712 | PubMed |
| 18 | 38099828 | High-Intensity Focused Ultrasound Surgery for Tumor Ablation: A Review of Current Applications. | Radiol Imaging Cancer | 2024 | https://conductscience.org/library/papers/38099828 | PubMed |
| 19 | 34960243 | Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34960243 | PubMed |
| 20 | 33447030 | Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/33447030 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42694636 | Nanotechnology-Driven Ultrasound/Photoacoustic Theranostics for Real-Time Imaging and Therapeutics. | Nanotheranostics | 2026 | https://conductscience.org/library/papers/42694636 | PubMed |
| 42230745 | Development and validation of a clinical prediction model for the success of focused ultrasound ablation system for the treatment of adenomyosis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42230745 | PubMed |
| 42068786 | Cavitation behaviors of genetically engineered bacterial protein nanoparticles induced by pulsed ultrasound. | Ultrason Sonochem | 2026 | https://conductscience.org/library/papers/42068786 | PubMed |
| 41764403 | Ultrasound-Responsive Engineered Bacteria for Targeted Cancer Therapy: Strategies, Mechanisms, and Applications. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41764403 | PubMed |
| 41584827 | Advances in novel biomaterials for cardiovascular tissue engineering and regenerative medicine. | PeerJ | 2026 | https://conductscience.org/library/papers/41584827 | PubMed |
| 41470489 | Multifunctional Nanoplatforms Bridging Diagnostics and Therapeutics in Cancer. | Micromachines (Basel) | 2025 | https://conductscience.org/library/papers/41470489 | PubMed |
| 41050416 | Multifunctional PLGA nanosystems: enabling integrated diagnostic and therapeutic strategies. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41050416 | PubMed |
| 40887201 | [Advances in multimodal biomedical imaging of small animals]. | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | 2025 | https://conductscience.org/library/papers/40887201 | PubMed |
| 40585028 | Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40585028 | PubMed |
| 40468414 | Genetically engineered bacteria-based nanocomposite synergistic HIFU for tumor therapy by changing the acoustic environment of tumor tissues. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40468414 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39385196
GET https://conductscience.org/api/papers/v1/39385196/references?page=2